Compound 18a5
Compound 18a5 is a lead small molecule for triple-negative breast cancer (TNBC) research, functioning through targeted degradation of Annexin A3 (ANXA3) . It has demonstrated promising activity in both in vitro cellular assays and in vivo xenograft models, supporting its investigation as a potential therapeutic agent.
Product Specifications
Field of Research
Pharmacology & Drug Discovery
Smiles
O=C (CSC (NC1C (N (C (C) C) C (C=CC=C2) =C2C (C3=CC=CC=C3) =N1) =O) =S) N (CC4) CCN4C5=NC=CC=C5
Molecular Formula
C30H32N6O2S2
Molecular Weight
572.74
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
RPU51568-01 50 µg
Recombinant Mitochondrial Transcription Termination Factor (MTERF)
Sign In for Pricing
View Details RPU51568-02 100 µg
Recombinant Mitochondrial Transcription Termination Factor (MTERF)
Sign In for Pricing
View Details RPU51568-03 1 mg
Recombinant Mitochondrial Transcription Termination Factor (MTERF)
Sign In for Pricing
View Details 
MBS7010637-01 0.02 mg
Recombinant Solanum lycopersicum Chlorophyll a-b binding protein 1C, chloroplastic (CAB1C)
Sign In for Pricing
View Details